DEXCOM INC

Key metrics

Financial performance

Over the last 9 fiscal years DEXCOM INC's revenue grew from $573.30M to $4.66B, a compound annual growth rate of 26.2%. Net profit margin expanded from -11.4% to 17.9% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (2,566 filings)

Recent press releases

• - Quarterly Results2026-05-14

  Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

• - Quarterly Results2026-05-14

  SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on Thursday, May 14,2026 from 1:15 PM until approximately 3:30 PM PDT (4:15 PM – 6:30 PM EDT). The event will include presentations from Dexcom management highlighting the company’s market opportunities, business strategy, innovation efforts, and long-term financial outlook.

• - Quarterly Results2026-04-30

  Dexcom Reports First Quarter 2026 Financial Results

• - Quarterly Results2026-04-30

  To listen to the conference call, please dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.

• - Quarterly Results2026-03-11

  Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

Similar companies

The largest companies sharing DEXCOM INC's SEC industry classification (surgical & medical instruments & apparatus).